Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl(4)-induced liver fibrosis

BACKGROUND: Rifaximin is a poorly absorbed broad-spectrum antibiotic used for hepatic encephalopathy. Although increased Lactobacillaceae and decreased Bacteroidetes abundance are characteristic of hepatic encephalopathy, rifaximin does not dramatically alter the stool microbiota. As the antimicrobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeuchi, Kazuhiko, Tsutsumi, Takeya, Ishizaka, Aya, Mizutani, Taketoshi, Sedohara, Ayako, Koga, Michiko, Tamaoki, Satoru, Yotsuyanagi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029291/
https://www.ncbi.nlm.nih.gov/pubmed/36945059
http://dx.doi.org/10.1186/s13099-023-00541-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029291/
https://www.ncbi.nlm.nih.gov/pubmed/36945059
http://dx.doi.org/10.1186/s13099-023-00541-4

Ejemplares similares